Related Experiment Video
Updated: Jun 25, 2026

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
Published on: November 13, 2015
The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases
Kunhua Song1, Johannes Backs, John McAnally
1Department of Molecular Biology, The University of Texas Southwestern Medical Center at Dallas, 6000 Harry Hines Blvd., Dallas, TX 75390, USA.
Abstract:
Postnatal cardiac myocytes respond to diverse signals by hypertrophic growth and activation of a fetal gene program. In an effort to discover regulators of cardiac hypertrophy, we performed a eukaryotic expression screen for activators of the atrial natriuretic factor (ANF) gene, a cardiac-specific marker of hypertrophic signaling. We discovered that a family of transcriptional coactivators, called CAMTAs, promotes cardiomyocyte hypertrophy and activates the ANF gene, at least in part, by associating with the cardiac homeodomain protein Nkx2-5. The transcriptional activity of CAMTAs is governed by association with class II histone deacetylases (HDACs), which negatively regulate cardiac growth. Mice homozygous for a mutation in a CAMTA gene are defective in cardiac growth in response to pressure overload and neurohumoral signaling, whereas mice lacking HDAC5, a class II HDAC, are sensitized to the prohypertrophic actions of CAMTA. These findings reveal a transcriptional regulatory mechanism that modulates cardiac growth and gene expression by linking hypertrophic signals to the cardiac genome.
Insights
Researchers identified CAMTA transcriptional coactivators as key regulators of cardiac hypertrophy. These proteins promote cardiomyocyte growth and activate the ANF gene by interacting with Nkx2-5, revealing a novel mechanism for cardiac gene regulation.
Area of Science:
- Cardiology
- Molecular Biology
- Gene Regulation
Background:
- Postnatal cardiac myocytes undergo hypertrophic growth and activate fetal gene programs in response to various signals.
- Cardiac hypertrophy is a critical process implicated in heart disease.
Purpose of the Study:
- To discover novel regulators of cardiac hypertrophy.
- To investigate the role of transcriptional coactivators in cardiac gene expression.
Main Methods:
- Performed a eukaryotic expression screen to identify activators of the atrial natriuretic factor (ANF) gene.
- Investigated the interaction between CAMTA coactivators, Nkx2-5, and class II histone deacetylases (HDACs).
- Utilized genetically modified mouse models (CAMTA knockout and HDAC5 knockout) to assess cardiac growth responses.
Main Results:
- Identified CAMTA family transcriptional coactivators as promoters of cardiomyocyte hypertrophy and ANF gene activation.
- Demonstrated that CAMTA function is regulated by association with class II HDACs, which inhibit cardiac growth.
- Showed that CAMTA mutations impair cardiac growth under stress, while HDAC5 deficiency sensitizes hearts to CAMTA's prohypertrophic effects.
Conclusions:
- CAMTA coactivators, in conjunction with Nkx2-5 and HDACs, form a critical regulatory axis for cardiac growth and gene expression.
- This pathway links hypertrophic signaling to the cardiac genome, offering potential therapeutic targets for heart disease.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Master Transcription Regulators
Co-activators and Co-repressors
Master Transcription Regulators

